Scientists are testing an entirely new way to fight heart disease: a gene-editing treatment that might offer a one-time fix ...

Beam Therapeutics recently announced that it secured a standby license with Kobe University and Bio Palette for key gene-editing patents and confirmed the upcoming resignation of board member Carole ...

The Canadian government's recent approval of the first gene-edited animal to enter the food system has reignited debates over ...

A research team has successfully demonstrated the world's first gene-editing treatment for Leber's hereditary optic ...

Faced with a life-threatening metabolic disease, KJ’s doctors at Children’s Hospital of Philadelphia sprinted to create a ...

The idea of self-amplifying gene editing is to get cells to pass on packages of CRISPR machinery to their neighbours, boosting the effect ...

Eli Lilly is flying high thanks to its success in the GLP-1 space, but what comes next?

Beam Therapeutics (BEAM) is back in focus after securing an expedited FDA approval pathway for its BEAM-302 program in alpha-1 antitrypsin deficiency, alongside a standby patent license with Kobe ...

For most of his 20 years, a New Jersey man knew pain as a daily reality. Now, after a one-time CRISPR gene-editing treatment at Children's Hospital of Philadelphia, Austin Louis says he is finally ...

A new skin-applied gene therapy uses lipid nanoparticles to deliver gene editing into skin stem cells, correcting ...

Extracellular vesicles (EVs) are tiny membrane-bound particles released by cells to transport proteins and other molecules to neighboring cells. Because of this natural delivery ability, EVs have ...